| Autor: |
Ljubicic Lidija, Janzic Urska, Unk Mojca, Terglav Ana Sophie, Mohorcic Katja, Seiwerth Fran, Bitar Lela, Badovinac Sonja, Plestina Sanja, Korsic Marta, Kukulj Suzana, Samarzija Miroslav, Jakopovic Marko |
| Jazyk: |
angličtina |
| Rok vydání: |
2023 |
| Předmět: |
|
| Zdroj: |
Radiology and Oncology, Vol 57, Iss 3, Pp 397-404 (2023) |
| Druh dokumentu: |
article |
| ISSN: |
1581-3207 |
| DOI: |
10.2478/raon-2023-0040 |
| Popis: |
The standard first-line systemic treatment for patients with non-oncogene addicted advanced nonsquamous non-small cell lung cancer (NSCLC) is immunotherapy with immune checkpoint inhibitors (ICI) and/or chemotherapy (ChT). Therapy after failing ICI +/− ChT remains an open question, and docetaxel plus nintedanib represent a valid second line option. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
